BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20574802)

  • 1. Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty.
    Noordin S; Waters TS; Garbuz DS; Duncan CP; Masri BA
    Clin Orthop Relat Res; 2011 Feb; 469(2):541-6. PubMed ID: 20574802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty: A Retrospective Study.
    Peck J; Kepecs DM; Mei B; Safir OA; Backstein D; Gross AE; Kuzyk PR
    J Bone Joint Surg Am; 2018 Sep; 100(17):1509-1516. PubMed ID: 30180060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic Acid Reduces Blood Transfusions in Revision Total Hip Arthroplasty.
    Park KJ; Couch CG; Edwards PK; Siegel ER; Mears SC; Barnes CL
    J Arthroplasty; 2016 Dec; 31(12):2850-2855.e1. PubMed ID: 27426220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One intraoperative dose of tranexamic Acid for patients having primary hip or knee arthroplasty.
    Ralley FE; Berta D; Binns V; Howard J; Naudie DD
    Clin Orthop Relat Res; 2010 Jul; 468(7):1905-11. PubMed ID: 20063079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous tranexamic acid for reducing perioperative blood loss during revision hip arthroplasty: A retrospective study.
    Wang Q; Yeersheng R; Li D; Yang Z; Kang P
    Acta Orthop Traumatol Turc; 2020 Sep; 54(5):519-523. PubMed ID: 33155563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Infected Total Hip Arthroplasty Undergoing 2-Stage Exchange Arthroplasty Experience Massive Blood Loss.
    Goel R; Buckley P; Sterbis E; Parvizi J
    J Arthroplasty; 2018 Nov; 33(11):3547-3550. PubMed ID: 30100135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
    Gill JB; Rosenstein A
    J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous tranexamic acid is associated with safe reduced blood loss and transfusion rate in one-stage exchange for infected hip arthroplasty.
    Abdelaziz H; Chaabene A; Schulmeyer J; Gehrke T; Haasper C; Hawi N; Citak M
    Jt Dis Relat Surg; 2021; 32(1):17-21. PubMed ID: 33463413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total hip arthroplasty.
    Hines JT; Hernandez NM; Amundson AW; Pagnano MW; Sierra RJ; Abdel MP
    Bone Joint J; 2019 Jun; 101-B(6_Supple_B):104-109. PubMed ID: 31146563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One Dose of Intravenous Tranexamic Acid Is Equivalent to Two Doses in Total Hip and Knee Arthroplasty.
    Wilde JM; Copp SN; McCauley JC; Bugbee WD
    J Bone Joint Surg Am; 2018 Jul; 100(13):1104-1109. PubMed ID: 29975264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous Tranexamic Acid for Reducing Perioperative Blood Loss During Revision Surgery for Vancouver Type B Periprosthetic Femoral Fractures After Total Hip Arthroplasty: A Retrospective Study.
    Wang QR; Yeersheng R; Li DH; Yang ZY; Kang PD
    Orthop Surg; 2020 Feb; 12(1):100-107. PubMed ID: 31884693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tranexamic acid in unilateral major revision total hip arthroplasty.
    Mei L; Li H; Zhu W; Luo Y; Mao X
    Ann Palliat Med; 2020 Sep; 9(5):2466-2473. PubMed ID: 32921073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tranexamic Acid Safely Reduced Blood Loss in Hemi- and Total Hip Arthroplasty for Acute Femoral Neck Fracture: A Randomized Clinical Trial.
    Watts CD; Houdek MT; Sems SA; Cross WW; Pagnano MW
    J Orthop Trauma; 2017 Jul; 31(7):345-351. PubMed ID: 28633147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
    Polanco-García M; Capielo AM; Miret X; Chamero A; Sainz J; Revilla E; Guinjoan A; Arranz T
    Med Clin (Barc); 2019 Feb; 152(3):90-97. PubMed ID: 29887176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
    Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
    J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.
    Bradley KE; Ryan SP; Penrose CT; Grant SA; Wellman SS; Attarian DE; Green CL; Risoli T; Bolognesi MP
    Bone Joint J; 2019 Sep; 101-B(9):1093-1099. PubMed ID: 31474134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical Tranexamic Acid is Equivalent to Targeted Preoperative Autologous Blood Donation in Total Hip Arthroplasty.
    Kasparek MF; Faschingbauer M; Waldstein W; Boettner CS; Boettner F
    J Arthroplasty; 2017 Apr; 32(4):1176-1179. PubMed ID: 27913130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial.
    Sershon RA; Fillingham YA; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Vail TP; Nam D; Nahhas C; Culvern C; Della Valle CJ;
    J Bone Joint Surg Am; 2020 Nov; 102(21):1883-1890. PubMed ID: 33148955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.
    Alvarez JC; Santiveri FX; Ramos I; Vela E; Puig L; Escolano F
    Transfusion; 2008 Mar; 48(3):519-25. PubMed ID: 18067499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.